{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T15:23:14Z","timestamp":1793287394845,"version":"4.5.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,5,20]],"date-time":"2020-05-20T00:00:00Z","timestamp":1589932800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,5,20]],"date-time":"2020-05-20T00:00:00Z","timestamp":1589932800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Obes"],"published-print":{"date-parts":[[2021,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background\/Objectives<\/jats:title>\n                <jats:p>Maternal glycaemia promotes fetal adiposity. Inositol, an insulin sensitizer, has been trialled for gestational diabetes prevention. The placenta has been implicated in how maternal hyperglycaemia generates fetal pathophysiology, but no studies have examined whether placental inositol biology is altered with maternal hyperglycaemia, nor whether such alterations impact fetal physiology. We aimed to investigate whether the effects of maternal glycaemia on offspring birthweight and adiposity at birth differed across placental inositol levels.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Using longitudinal data from the Growing Up in Singapore Towards healthy Outcomes cohort, maternal fasting glucose (FPG) and 2-hour plasma glucose (2hPG) were obtained in pregnant women by a 75-g oral glucose tolerance test around 26 weeks\u2019 gestation. Relative placental inositol was quantified by liquid chromatography-mass spectrometry. Primary outcomes were birthweight (<jats:italic>n<\/jats:italic>\u2009=\u2009884) and abdominal adipose tissue (AAT) volumes measured by neonatal MRI scanning in a subset (<jats:italic>n<\/jats:italic>\u2009=\u2009262) of term singleton pregnancies. Multiple linear regression analyses were performed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Placental inositol was lower in those with higher 2hPG, no exposure to tobacco smoke antenatally, with vaginal delivery and shorter gestation. Positive associations of FPG with birthweight (adjusted \u03b2 [95% CI] 164.8\u2009g [109.1, 220.5]) and AAT (17.3\u2009ml [11.9, 22.6] per mmol glucose) were observed, with significant interactions between inositol tertiles and FPG in relation to these outcomes (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05). Stratification by inositol tertiles showed that each mmol\/L increase in FPG was associated with increased birthweight and AAT volume among cases within the lowest (birthweight\u2009=\u2009174.2\u2009g [81.2, 267.2], AAT\u2009=\u200921.0\u2009ml [13.1, 28.8]) and middle inositol tertiles (birthweight\u2009=\u2009202.0\u2009g [103.8, 300.1], AAT\u2009=\u200919.7\u2009ml [9.7, 29.7]). However, no significant association was found among cases within the highest tertile (birthweight\u2009=\u200981.0\u2009g [\u221221.2, 183.2], AAT\u2009=\u20090.8\u2009ml [\u22128.4, 10.0]).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>High placental inositol may protect the fetus from the pro-adipogenic effects of maternal glycaemia. Studies are warranted to investigate whether prenatal inositol supplementation can increase placental inositol and reduce fetal adiposity.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1038\/s41366-020-0596-5","type":"journal-article","created":{"date-parts":[[2020,5,20]],"date-time":"2020-05-20T11:03:00Z","timestamp":1589972580000},"page":"247-257","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["High placental inositol content associated with suppressed pro-adipogenic effects of maternal glycaemia in offspring: the GUSTO cohort"],"prefix":"10.1038","volume":"45","author":[{"given":"Anne H. Y.","family":"Chu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mya T.","family":"Tint","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsin F.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerard","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen Lun","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dedreia","family":"Tull","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brunda","family":"Nijagal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinod K.","family":"Narayana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2593-4665","authenticated-orcid":false,"given":"Peter J.","family":"Meikle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth T. E.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4044-9104","authenticated-orcid":false,"given":"Rohan M.","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Chi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian K. P.","family":"Yap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1945-0266","authenticated-orcid":false,"given":"Kok Hian","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynette P.","family":"Shek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yap-Seng","family":"Chong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter D.","family":"Gluckman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1253-0557","authenticated-orcid":false,"given":"Yung Seng","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marielle V.","family":"Fortier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4643-0618","authenticated-orcid":false,"given":"Keith M.","family":"Godfrey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan G.","family":"Eriksson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neerja","family":"Karnani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiao-Yng","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,20]]},"reference":[{"key":"596_CR1","doi-asserted-by":"publisher","first-page":"i4694","DOI":"10.1136\/bmj.i4694","volume":"354","author":"D Farrar","year":"2016","unstructured":"Farrar D, Simmonds M, Bryant M, Sheldon TA, Tuffnell D, Golder S, et al. Hyperglycaemia and risk of adverse perinatal outcomes: systematic review and meta-analysis. BMJ. 2016;354:i4694.","journal-title":"BMJ"},{"key":"596_CR2","doi-asserted-by":"publisher","first-page":"2200","DOI":"10.2337\/dc09-1088","volume":"32","author":"Z Ker\u00e9nyi","year":"2009","unstructured":"Ker\u00e9nyi Z, Tam\u00e1s G, Kivim\u00e4ki M, P\u00e9terfalvi A, Madar\u00e1sz E, Bosny\u00e1k Z, et al. Maternal glycemia and risk of large-for-gestational-age babies in a population-based screening. Diabetes Care. 2009;32:2200\u20135.","journal-title":"Diabetes Care"},{"key":"596_CR3","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1056\/NEJMoa0707943","volume":"358","author":"BE Metzger","year":"2008","unstructured":"Metzger BE, Contreras M, Sacks DA, Watson W, Dooley SL, Foderaro M, et al. Hyperglycemia and adverse pregnancy outcomes. New Engl J Med. 2008;358:1991\u20132002.","journal-title":"New Engl J Med"},{"key":"596_CR4","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1007\/s00125-018-4809-6","volume":"62","author":"WL Lowe","year":"2019","unstructured":"Lowe WL, Lowe LP, Kuang A, Catalano PM, Nodzenski M, Talbot O, et al. Maternal glucose levels during pregnancy and childhood adiposity in the Hyperglycemia and Adverse Pregnancy Outcome Follow-up Study. Diabetologia. 2019;62:598\u2013610.","journal-title":"Diabetologia"},{"key":"596_CR5","first-page":"1049","volume":"47","author":"J Pedersen","year":"1952","unstructured":"Pedersen J. Diabetes and pregnancy; blood sugar of newborn infants during fasting and glucose administration. Nordisk Med. 1952;47:1049.","journal-title":"Nordisk Med"},{"key":"596_CR6","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1016\/S0002-9378(03)00828-7","volume":"189","author":"PM Catalano","year":"2003","unstructured":"Catalano PM, Thomas A, Huston-Presley L, Amini SB. Increased fetal adiposity: a very sensitive marker of abnormal in utero development. Am J Obstet Gynecol. 2003;189:1698\u2013704.","journal-title":"Am J Obstet Gynecol"},{"key":"596_CR7","doi-asserted-by":"publisher","first-page":"854","DOI":"10.2337\/dc12-1371","volume":"36","author":"R D\u2019Anna","year":"2013","unstructured":"D\u2019Anna R, Scilipoti A, Giordano D, Caruso C, Cannata ML, Interdonato ML, et al. myo-Inositol supplementation and onset of gestational diabetes mellitus in pregnant women with a family history of type 2 diabetes: a prospective, randomized, placebo-controlled study. Diabetes Care. 2013;36:854\u20137.","journal-title":"Diabetes Care"},{"key":"596_CR8","doi-asserted-by":"publisher","first-page":"440","DOI":"10.3109\/09513590.2011.633665","volume":"28","author":"R D\u2019anna","year":"2012","unstructured":"D\u2019anna R, Di Benedetto V, Rizzo P, Raffone E, Interdonato ML, Corrado F, et al. Myo-inositol may prevent gestational diabetes in PCOS women. Gynecol Endocrinol. 2012;28:440\u20132.","journal-title":"Gynecol Endocrinol"},{"key":"596_CR9","doi-asserted-by":"publisher","first-page":"3234","DOI":"10.3109\/14767058.2015.1121478","volume":"29","author":"A Santamaria","year":"2016","unstructured":"Santamaria A, Di Benedetto A, Petrella E, Pintaudi B, Corrado F, D\u2019Anna R, et al. Myo-inositol may prevent gestational diabetes onset in overweight women: a randomized, controlled trial. J Matern Fetal Neonatal Med. 2016;29:3234\u20137.","journal-title":"J Matern Fetal Neonatal Med"},{"key":"596_CR10","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1097\/AOG.0000000000000958","volume":"126","author":"R D\u2019Anna","year":"2015","unstructured":"D\u2019Anna R, Di Benedetto A, Scilipoti A, Santamaria A, Interdonato ML, Petrella E, et al. Myo-inositol supplementation for prevention of gestational diabetes in obese pregnant women: a randomized controlled trial. Obstet Gynecol. 2015;126:310\u20135.","journal-title":"Obstet Gynecol"},{"key":"596_CR11","doi-asserted-by":"publisher","first-page":"759","DOI":"10.2337\/dc16-2449","volume":"40","author":"M Farren","year":"2017","unstructured":"Farren M, Daly N, McKeating A, Kinsley B, Turner MJ, Daly S. The prevention of gestational diabetes mellitus with antenatal oral inositol supplementation: a randomized controlled trial. Diabetes Care. 2017;40:759\u201363.","journal-title":"Diabetes Care"},{"key":"596_CR12","doi-asserted-by":"publisher","DOI":"10.2337\/dc17-0847","volume":"40","author":"B Pintaudi","year":"2017","unstructured":"Pintaudi B, Di Vieste G. Comment on Farren et al. The prevention of gestational diabetes mellitus with antenatal oral inositol supplementation: a randomized controlled trial. Diabetes Care. 2017;40:e172.","journal-title":"Diabetes Care"},{"key":"596_CR13","doi-asserted-by":"publisher","first-page":"967","DOI":"10.3109\/14767058.2013.766691","volume":"26","author":"B Matarrelli","year":"2013","unstructured":"Matarrelli B, Vitacolonna E, D\u2019angelo M, Pavone G, Mattei PA, Liberati M, et al. Effect of dietary myo-inositol supplementation in pregnancy on the incidence of maternal gestational diabetes mellitus and fetal outcomes: a randomized controlled trial. J Matern Fetal Neonatal Med. 2013;26:967\u201372.","journal-title":"J Matern Fetal Neonatal Med"},{"key":"596_CR14","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1146\/annurev.nu.06.070186.003023","volume":"6","author":"BJ Holub","year":"1986","unstructured":"Holub BJ. Metabolism and function of myo-inositol and inositol phospholipids. Annu Rev Nutr. 1986;6:563\u201397.","journal-title":"Annu Rev Nutr"},{"key":"596_CR15","doi-asserted-by":"publisher","first-page":"777","DOI":"10.2337\/dc12-2505","volume":"36","author":"DR Coustan","year":"2013","unstructured":"Coustan DR. Can a dietary supplement prevent gestational diabetes mellitus? Diabetes Care. 2013;36:777\u20139.","journal-title":"Diabetes Care"},{"key":"596_CR16","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1210\/jc.2011-1800","volume":"97","author":"BC Staat","year":"2012","unstructured":"Staat BC, Galan HL, Harwood JE, Lee G, Marconi AM, Paolini CL, et al. Transplacental supply of mannose and inositol in uncomplicated pregnancies using stable isotopes. J Clin Endocrinol Metab. 2012;97:2497\u2013502.","journal-title":"J Clin Endocrinol Metab"},{"key":"596_CR17","first-page":"13","volume":"8","author":"N Toh","year":"1987","unstructured":"Toh N, Inoue T, Tanaka H, Kimoto E. Polyol accumulation in human placenta and umbilical cord. Biol Res Pregnancy Perinatol. 1987;8:13\u20135. (1 1ST Half)","journal-title":"Biol Res Pregnancy Perinatol"},{"key":"596_CR18","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1093\/ije\/dyt125","volume":"43","author":"SE Soh","year":"2014","unstructured":"Soh SE, Tint MT, Gluckman PD, Godfrey KM, Rifkin-Graboi A, Chan YH, et al. Cohort profile: Growing Up in Singapore Towards healthy Outcomes (GUSTO) birth cohort study. Int J Epidemiol. 2014;43:1401\u20139.","journal-title":"Int J Epidemiol"},{"key":"596_CR19","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S0140-6736(03)15268-3","volume":"363","author":"WHO Expert Consultation.","year":"2004","unstructured":"WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004;363:157\u201363.","journal-title":"Lancet"},{"key":"596_CR20","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1093\/ntr\/nty148","volume":"21","author":"S Ng","year":"2019","unstructured":"Ng S, Aris IM, Tint MT, Gluckman PD, Godfrey KM, Shek LP, et al. High maternal circulating cotinine during pregnancy is associated with persistently shorter stature from birth to five years in an Asian cohort. Nicotine Tob Res. 2019;21:1103\u201312.","journal-title":"Nicotine Tob Res"},{"key":"596_CR21","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1148\/radiology.182.2.1732970","volume":"182","author":"FP Hadlock","year":"1992","unstructured":"Hadlock FP, Shah YP, Kanon DJ, Lindsey JV. Fetal crown-rump length: reevaluation of relation to menstrual age (5-18 weeks) with high-resolution real-time US. Radiology. 1992;182:501\u20135.","journal-title":"Radiology"},{"key":"596_CR22","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1016\/S0140-6736(11)60364-4","volume":"377","author":"RT Mikolajczyk","year":"2011","unstructured":"Mikolajczyk RT, Zhang J, Betran AP, Souza JP, Mori R, G\u00fclmezoglu AM, et al. A global reference for fetal-weight and birthweight percentiles. Lancet. 2011;377:1855\u201361.","journal-title":"Lancet"},{"key":"596_CR23","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.3945\/ajcn.115.108738","volume":"103","author":"MT Tint","year":"2016","unstructured":"Tint MT, Fortier MV, Godfrey KM, Shuter B, Kapur J, Rajadurai VS, et al. Abdominal adipose tissue compartments vary with ethnicity in Asian neonates: Growing Up in Singapore Toward Healthy Outcomes birth cohort study. Am J Clin Nutr. 2016;103:1311\u20137.","journal-title":"Am J Clin Nutr"},{"key":"596_CR24","doi-asserted-by":"publisher","DOI":"10.1111\/cmi.12685","volume":"19","author":"RJ Stewart","year":"2017","unstructured":"Stewart RJ, Whitehead L, Nijagal B, Sleebs BE, Lessene G, McConville MJ, et al. Analysis of Ca(2)(+) mediated signaling regulating Toxoplasma infectivity reveals complex relationships between key molecules. Cell Microbiol. 2017;19:e12685.","journal-title":"Cell Microbiol"},{"key":"596_CR25","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1093\/carcin\/bgu071","volume":"35","author":"AJ Cross","year":"2014","unstructured":"Cross AJ, Boca S, Freedman ND, Caporaso NE, Huang WY, Sinha R, et al. Metabolites of tobacco smoking and colorectal cancer risk. Carcinogenesis. 2014;35:1516\u201322.","journal-title":"Carcinogenesis"},{"key":"596_CR26","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1210\/jc.2013-2738","volume":"99","author":"IM Aris","year":"2014","unstructured":"Aris IM, Soh SE, Tint MT, Liang S, Chinnadurai A, Saw SM, et al. Effect of maternal glycemia on neonatal adiposity in a multiethnic Asian birth cohort. J Clin Endocrinol Metab. 2014;99:240\u20137.","journal-title":"J Clin Endocrinol Metab"},{"key":"596_CR27","doi-asserted-by":"publisher","first-page":"S120","DOI":"10.1111\/j.1753-4887.2004.tb00081.x","volume":"62","author":"FX Pi-Sunyer","year":"2004","unstructured":"Pi-Sunyer FX. The epidemiology of central fat distribution in relation to disease. Nutr Rev. 2004;62:S120\u20136.","journal-title":"Nutr Rev"},{"key":"596_CR28","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1530\/JOE-19-0267","volume":"243","author":"OC Watkins","year":"2019","unstructured":"Watkins OC, Islam MO, Selvam P, Pillai RA, Cazenave-Gassiot A, et al. Myo-inositol alters 13C-labeled fatty acid metabolism in human placental explants. J Endocrinol. 2019;243:73\u201384.","journal-title":"J Endocrinol"},{"key":"596_CR29","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1016\/j.biochi.2013.05.011","volume":"95","author":"ML Croze","year":"2013","unstructured":"Croze ML, Soulage CO. Potential role and therapeutic interests of myo-inositol in metabolic diseases. Biochimie. 2013;95:1811\u201327.","journal-title":"Biochimie"},{"key":"596_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-017-1875-x","volume":"18","author":"KM Godfrey","year":"2017","unstructured":"Godfrey KM, Cutfield W, Chan SY, Baker PN, Chong YS, NiPPeR Study Group. Nutritional Intervention Preconception and During Pregnancy to Maintain Healthy Glucose Metabolism and Offspring Health (\u201cNiPPeR\u201d): study protocol for a randomised controlled trial. Trials. 2017;18:131.","journal-title":"Trials"}],"container-title":["International Journal of Obesity"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41366-020-0596-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41366-020-0596-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41366-020-0596-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:18:05Z","timestamp":1684617485000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41366-020-0596-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,20]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["596"],"URL":"https:\/\/doi.org\/10.1038\/s41366-020-0596-5","relation":{},"ISSN":["0307-0565","1476-5497"],"issn-type":[{"value":"0307-0565","type":"print"},{"value":"1476-5497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,20]]},"assertion":[{"value":"2 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"SYC, YSC and KMG have received reimbursement for speaking at conferences sponsored by companies selling nutritional products. YSC, KMG, NK, and SYC are part of an academic consortium that has received research funding from Abbott Nutrition, Nestec and Danone. SYC, YSC and KMG are co-inventors on issued and pending patents, which covers the use of inositol in human health applications. These patents do not draw on results reported in this manuscript. The other authors have no financial or personal conflict of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}